Treatment for stress-induced exhaustion disorder needs to be relooked: Researchers
Traditional treatment can tend to overlook important psychological and social aspects of stress-induced exhaustion disorder, researchers said on Monday, adding that the concept of stress needs to be discussed from a new perspective
image for illustrative purpose
New Delhi, June 17: Traditional treatment can tend to overlook important psychological and social aspects of stress-induced exhaustion disorder, researchers said on Monday, adding that the concept of stress needs to be discussed from a new perspective.
Despite stress being central to human development, the focus is often on the negative aspects of stress.
A new thesis at Uppsala University in Sweden questioned the traditional view of stress-induced exhaustion disorder and introduced a new model that puts more focus on meaningfulness rather than recovery.
“There are no established evidence-based models for the psychological treatment of stress-induced exhaustion disorder. The concepts of ‘recovery’ and ‘stress’ are so widely accepted in our current era that it is difficult to examine them critically,” said Jakob Clason van de Leur from the Department of Psychology at Uppsala University.
It’s easy to think that patients with stress-related exhaustion should prioritise rest and relaxation.
"But an overly one-sided focus on recovery can lead to a passive existence that it’s easy to get stuck in and can instead become harmful over time,” van de Leur added.
He has followed 915 patients with stress-related exhaustion who have participated in comprehensive rehabilitation programmes, including medical, psychological, and physiotherapeutic methods.
While the results are positive, he said this approach is relatively ineffective overall.
“The treatments used to last up to one year when I started - now we are working on a 12-week digital programme,” van de Leur informed.
Despite being a small study, "the results show similar effects to our previous six-month treatment programme, using only a quarter of the clinical resources. This means that the treatment can be made available to more patients in the healthcare system,” the researchers explained.